If you made any changes in Pure these will be visible here soon.

Research Output 2015 2019

  • 4 Article
  • 2 Meeting Abstract
2019

Dose-escalation study of G1T48, an oral selective estrogen receptor degrader (SERD), in postmenopausal women with ER+/HER2- locally advanced or metastatic breast cancer (ABC)

Dees, E. C., Aftimos, P. G., Menke, C. W., De Vries, E. G. E., Neven, P., Pegram, M. D., Iqbal, R., Boers, J., Xiao, J., Sipes, C., Li, C., Sorrentino, J. A., Malik, R. & Beelen, A. P., 1 Oct 2019, In : Annals of Oncology. 30, Supplement 5

Research output: Contribution to journalMeeting AbstractAcademic

Open Access
2018

Validation of [18F]FLT as a perfusion-independent imaging biomarker of tumour response in EGFR-mutated NSCLC patients undergoing treatment with an EGFR tyrosine kinase inhibitor

Iqbal, R., Kramer, G. M., Frings, V., Smit, E. F., Hoekstra, O. S., Boellaard, R. & on behalf of the QuIC-ConCePT Consortium, 1 Jan 2018, In : EJNMMI Research. 8, 22.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access